16 results
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Overview of Treatment Agents ... for COVID-19 - ... 2020 #Drugs #Medications ... #Pharmacology # ... Table #Management
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Pain Assessment ... and Management Initiative ... Non-Opioid Analgesics - Agents ... #Pain #Pharmacology ... NonOpioid #Analgesics #Medications
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
and Management Initiative ... Medications: ... Agent, Initiation ... #Pain #Pharmacology ... #Neuropathic #Medications
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Pain Assessment ... and Management Initiative ... Muscle Relaxants - Agents ... #Pain #Pharmacology ... Relaxers #Relaxants #Medications
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Pain Assessment ... and Management Initiative ... Distribution, Agents ... #Pain #Pharmacology ... Nerve #Blocks #Medications
Therapy for AL Amyloidosis 2019 
 - Antibodies (Plasma cells) 
 - Proteasome Inhibitors 
 -
Therapy for AL Amyloidosis ... - Alkylating Agents ... ALAmyloidosis #Therapy #Medications ... #Therapies #Pharmacology ... #Management #Classes
Hydroxychloroquine and Chloroquine in COVID19

Dosing:
Hydroxychloroquine:
 - 400mg PO BID on the first day, followed by 200mg
Chloroquine in COVID19 ... - Second line agent ... #Chloroquine #COVID19 ... #HCQ #Pharmacology ... #Management #Medications
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
Pain Assessment ... and Nebulized Medications ... - Agents and Dosing ... Pain #Pharmacology ... Intranasal #Nebulized #Medications
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Anti-IL6 Agents ... Siltuximab) in COVID19 ... correlate with severe COVID ... #Pharmacology # ... Management #Medications
A quick infographic describing some of the common reversal agents used by anesthesiologists, their mechanism of
#management #anesthesia ... anesthesiology #treatment #medications ... References: Pani ... Pharmacology of ... neuromuscular pharmacology